|
Brayer, J B; Cha, S; Nagashima, H et al. (2001) IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome. Scand J Immunol 54:133-40
|
|
Cha, S; van Blockland, S C; Versnel, M A et al. (2001) Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet 18:143-60
|
|
Brayer, J; Lowry, J; Cha, S et al. (2000) Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy. J Rheumatol 27:1896-904
|
|
Yamachika, S; Brayer, J; Oxford, G E et al. (2000) Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy. Clin Exp Rheumatol 18:233-40
|
|
Humphreys-Beher, M G; Peck, A B (1999) New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 44 Suppl 1:S21-5
|
|
Humphreys-Beher, M G; Brayer, J; Yamachika, S et al. (1999) An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 49:7-10
|
|
Robinson, C P; Yamachika, S; Bounous, D I et al. (1998) A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum 41:150-6
|
|
Humphreys-Beher, M G; Yamachika, S; Yamamoto, H et al. (1998) Salivary gland changes in the NOD mouse model for Sjogren's syndrome: is there a non-immune genetic trigger? Eur J Morphol 36 Suppl:247-51
|
|
Kong, L; Robinson, C P; Peck, A B et al. (1998) Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 16:675-81
|
|
Yamachika, S; Nanni, J M; Nguyen, K H et al. (1998) Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjogren's syndrome. J Rheumatol 25:2371-80
|
Showing the most recent 10 out of 24 publications
